Traditional Chinese Medicine is Associated with the Reduction in Endpoint Events in Patients with Gouty Arthritis: Cohort Study and Association Rule Analysis
Yiming Chen,Jian Liu,Chengzhi Cong,Yang Li,Yuedi Hu
DOI: https://doi.org/10.2147/ijgm.s451097
IF: 2.145
2024-02-14
International Journal of General Medicine
Abstract:Yiming Chen, 1, 2 Jian Liu, 1, 2 Chengzhi Cong, 1 Yang Li, 1 Yuedi Hu 1 1 The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230038, People's Republic of China; 2 Anhui Key Laboratory of Application and Development of Internal medicine of Modern Chinese Medicine, Hefei, Anhui, 230038, People's Republic of China Correspondence: Jian Liu, Email Objective: This study aimed to evaluate the effect of traditional Chinese medicine (TCM) on endpoint events in patients with gouty arthritis (GA). Methods and Materials: A total of 2091 hospitalized GA patients were followed up by telephone, and propensity score matching (PSM) was used to reduce potential bias in the study design. Cox proportional risk model and Kaplan-Meier survival curve were utilized to analyze the impact and time effect of factors on the readmission of GA patients. The differences of laboratory indexes before and after treatment between the low and high exposure groups were compared, and the types and frequencies of medicines in all patients were counted. Association rule analysis was performed to investigate the association between TCM and test indexes or endpoint events. Results: After 1:1 PSM, 187 patients were enrolled in the TCM group and 187 patients in the non-TCM group. The incidence of readmission, new tophus, and all-cause death was lower in the TCM group than that in the non-TCM group (P < 0.05). Cox proportional risk regression analysis showed that TCM, NSAIDs and uric acid lowering drug were independent protective factors for GA readmission. The protective effect was enhanced by the prolongation of TCM treatment and the drug combinations. Kaplan-Meier survival curves indicated a significantly lower readmission rate in the high exposure group than in the low exposure group (P < 0.01). Compared with before treatment, NLR, hs-CRP, UA, TC and other laboratory indexes of the low and high exposure groups were improved after treatment (P < 0.01); The improvement of TG and TC in the high exposure group was more significant than the low exposure group (P < 0.01). The analysis of medicines used by all patients identified the top 20 Chinese herbal medicines and the top 2 Chinese patent medicines. The core drugs identified through association rule analysis that can improve test index and reduce the incidence of endpoint events include Yiyiren, Danshen, and HQC, among others. The network diagram of association rule analysis intuitively shows the relationship between core drugs and "improvement of indicators" and "the absence of endpoint events". Conclusion: TCM is associated with a reduced incidence of endpoint events in patients with GA. Keywords: gouty arthritis, cohort study, traditional Chinese medicine, Chinese patent medicine, neutrophil to lymphocyte ratio Gouty arthritis (GA) is the most common form of Crystal arthritis associated with diet, obesity, and genetics. Pathologically, GA is triggered by the deposition of sodium urate crystals in joints due to excessive production or impaired excretion of uric acid (UA). 1,2 GA typically presents with painful redness, swelling, and even restricted movement of joints. 3 The incidence of GA is on the rise in the past 10 years and shows a younger trend, and men are more prone to GA onset than women. 4,5 Moreover, GA patients at the advanced stage are vulnerable to severe complications such as cardio-cerebrovascular disease, kidney disease, and liver disease, which significantly compromise the quality of life and pose heavy economic burdens. 6 Encouragingly, traditional Chinese medicine (TCM) has shown promising efficacy in alleviating the clinical symptoms of GA. A randomized controlled trial of Qingre Lishi Decoction(QLRD) 7 demonstrated that the QLRD group was outperformed the control group (basic treatment and colchicine tablets) in improving joint symptom, effective rate, uric acid (UA), erythrocyte sedimentation rate (ESR), interleukin-1β(IL-1β), NALP3. Some researchers 8 have found that GA patients receiving the external application of compound Qingbi granules combined with basic medicine exhibited better joint pain and swelling relief, CRP and UA level, onset time, and efficacy duration than those treated with basic medicine alone, and no significant difference was found in the incidence of adverse events between the groups. Many scholars believe that the application of TCM can inhibit inflammatory responses, promote the dissolution and excretion of urate crystals, and prevent liver and kidney damage in GA patients. 9–11 Since long-term use of Western medicine alone may cause damage to liver and kidney f -Abstract Truncated-
medicine, general & internal